跳到正文

REGENERON PHARMACEUTICALS, INC. 提交8-K,披露经营业绩与财务报表附件

SEC EDGAR 8-K·(美东 10月30日 06:50)· 3 天前

8-K - REGENERON PHARMACEUTICALS, INC. (0000872589) (Filer)

AI 导读

REGENERON PHARMACEUTICALS, INC.(CIK: 0000872589)于2026-10-30提交8-K,报告日期为2026-10-30,共13份文件。文件列明项目包括 Item 2.02(经营业绩与财务状况)和 Item 9.01(财务报表与附件)。公司地址为纽约州塔里敦OLD SAW MILL RIVER ROAD 777号,SIC行业为2834药品制剂。

报错 · 内容有误?请告诉我们。

正文 · 原文

Filing Date

2026-10-30

Accepted

2026-10-30 06:50:20

Documents

13

Period of Report

2026-10-30

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591

Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000

REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 261504342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

来源:SEC EDGAR 8-K · sec.gov